• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过细胞游离信使 RNA 谱分析在小鼠中研究系统性和器官特异性炎症反应的细胞外通讯。

Survey of extracellular communication of systemic and organ-specific inflammatory responses through cell free messenger RNA profiling in mice.

机构信息

Molecular Stethoscope Inc., 259 E Grand Avenue, South San Francisco, CA 94080, United States.

Department of Bioengineering and Department of Applied Physics, Stanford University and Chan Zuckerberg Biohub, Stanford, CA 94305, United States.

出版信息

EBioMedicine. 2022 Sep;83:104242. doi: 10.1016/j.ebiom.2022.104242. Epub 2022 Aug 30.

DOI:10.1016/j.ebiom.2022.104242
PMID:36054939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9437808/
Abstract

BACKGROUND

Inflammatory and immune responses are essential and dynamic biological processes that protect the body against acute and chronic adverse stimuli. While conventional protein markers have been used to evaluate systemic inflammatory response, the immunological response to stimulation is complex and involves modulation of a large set of genes and interacting signalling pathways of innate and adaptive immune systems. There is a need for a non-invasive tool that can comprehensively evaluate and monitor molecular dysregulations associated with inflammatory and immune responses in circulation and in inaccessible solid organs.

METHODS

Here we utilized cell-free messenger RNA (cf-mRNA) RNA-Seq whole transcriptome profiling and computational biology to temporally assess lipopolysaccharide (LPS) induced and JAK inhibitor modulated inflammatory and immune responses in mouse plasma samples.

FINDINGS

Cf-mRNA profiling displayed a pattern of systemic immune responses elicited by LPS and dysregulation of associated pathways. Moreover, attenuation of several inflammatory pathways, including STAT and interferon pathways, were observed following the treatment of JAK inhibitor. We further identified the dysregulation of liver-specific transcripts in cf-mRNA which reflected changes in the gene-expression pattern in this generally inaccessible biological compartment.

INTERPRETATION

Using a preclinical mouse model, we demonstrated the potential of plasma cf-mRNA profiling for systemic and organ-specific characterization of drug-induced molecular alterations that are associated with inflammatory and immune responses.

FUNDING

Molecular Stethoscope.

摘要

背景

炎症和免疫反应是保护身体免受急性和慢性不良刺激的必要和动态的生物学过程。虽然传统的蛋白质标志物已被用于评估全身炎症反应,但对刺激的免疫反应是复杂的,涉及到固有和适应性免疫系统的大量基因和相互作用的信号通路的调节。需要一种非侵入性的工具,可以全面评估和监测与循环和难以接近的实体器官中的炎症和免疫反应相关的分子失调。

方法

在这里,我们利用无细胞信使 RNA(cf-mRNA)RNA-Seq 全转录组谱分析和计算生物学,在小鼠血浆样本中,从时间上评估脂多糖(LPS)诱导和 JAK 抑制剂调节的炎症和免疫反应。

发现

cf-mRNA 分析显示了 LPS 引发的全身免疫反应模式和相关途径的失调。此外,在 JAK 抑制剂治疗后,观察到几种炎症途径(包括 STAT 和干扰素途径)的减弱。我们进一步确定了 cf-mRNA 中肝脏特异性转录物的失调,这反映了这个通常难以进入的生物隔室中基因表达模式的变化。

解释

使用临床前小鼠模型,我们证明了血浆 cf-mRNA 分析在与炎症和免疫反应相关的药物诱导的分子改变的全身和器官特异性特征化方面的潜力。

资金来源

分子听诊器。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af2/9437808/9b841ff7c888/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af2/9437808/f9e34df8754e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af2/9437808/03a6d2b50301/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af2/9437808/e382eee0f322/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af2/9437808/9609e997319b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af2/9437808/9b841ff7c888/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af2/9437808/f9e34df8754e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af2/9437808/03a6d2b50301/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af2/9437808/e382eee0f322/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af2/9437808/9609e997319b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af2/9437808/9b841ff7c888/gr5.jpg

相似文献

1
Survey of extracellular communication of systemic and organ-specific inflammatory responses through cell free messenger RNA profiling in mice.通过细胞游离信使 RNA 谱分析在小鼠中研究系统性和器官特异性炎症反应的细胞外通讯。
EBioMedicine. 2022 Sep;83:104242. doi: 10.1016/j.ebiom.2022.104242. Epub 2022 Aug 30.
2
Noninvasive stratification of nonalcoholic fatty liver disease by whole transcriptome cell-free mRNA characterization.采用全转录组游离 mRNA 特征分析对非酒精性脂肪性肝病进行无创分层。
Am J Physiol Gastrointest Liver Physiol. 2021 Apr 1;320(4):G439-G449. doi: 10.1152/ajpgi.00397.2020. Epub 2021 Jan 27.
3
Decoding bioactive signals of the RNA secretome: the cell-free messenger RNA catalogue.解码 RNA 分泌组的生物活性信号:无细胞信使 RNA 目录。
Expert Rev Mol Med. 2024 Apr 29;26:e12. doi: 10.1017/erm.2024.12.
4
Non-invasive characterization of human bone marrow stimulation and reconstitution by cell-free messenger RNA sequencing.基于游离信使 RNA 测序的人类骨髓刺激和重建的无创特征分析。
Nat Commun. 2020 Jan 21;11(1):400. doi: 10.1038/s41467-019-14253-4.
5
Acute systemic inflammatory response to lipopolysaccharide stimulation in pigs divergently selected for residual feed intake.猪对脂多糖刺激的急性全身炎症反应与饲料采食量残留量的差异选择。
BMC Genomics. 2019 Oct 11;20(1):728. doi: 10.1186/s12864-019-6127-x.
6
Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes.转录组分析揭示了 JAK 蛋白酪氨酸激酶 2(Tyk2)对干扰素反应性和代谢基因表达的重要影响。
BMC Genomics. 2010 Mar 25;11:199. doi: 10.1186/1471-2164-11-199.
7
Disparate roles of marrow- and parenchymal cell-derived TLR4 signaling in murine LPS-induced systemic inflammation.骨髓细胞和实质细胞 TLR4 信号在 LPS 诱导的小鼠全身炎症中的不同作用。
Sci Rep. 2012;2:918. doi: 10.1038/srep00918. Epub 2012 Dec 4.
8
The potential sensing molecules and signal cascades for protecting teleost fishes against lipopolysaccharide.用于保护硬骨鱼类免受脂多糖侵害的潜在感应分子和信号级联。
Fish Shellfish Immunol. 2020 Feb;97:235-247. doi: 10.1016/j.fsi.2019.12.050. Epub 2019 Dec 19.
9
Construction and analysis for dys-regulated lncRNAs and mRNAs in LPS-induced porcine PBMCs.构建和分析 LPS 诱导的猪 PBMCs 中失调的 lncRNAs 和 mRNAs。
Innate Immun. 2021 Feb;27(2):170-183. doi: 10.1177/1753425920983869. Epub 2021 Jan 27.
10
Noninvasive characterization of Alzheimer's disease by circulating, cell-free messenger RNA next-generation sequencing.通过循环、无细胞信使 RNA 下一代测序对阿尔茨海默病进行无创特征分析。
Sci Adv. 2020 Dec 9;6(50). doi: 10.1126/sciadv.abb1654. Print 2020 Dec.

引用本文的文献

1
Physicochemical properties, biological activities, applications, and protective potential of the skeletal system of polysaccharides: a review.多糖骨骼系统的物理化学性质、生物活性、应用及保护潜力:综述
Front Pharmacol. 2025 Mar 13;16:1570095. doi: 10.3389/fphar.2025.1570095. eCollection 2025.
2
Characterizing the Cell-Free Transcriptome in a Humanized Diffuse Large B-Cell Lymphoma Patient-Derived Tumor Xenograft Model for RNA-Based Liquid Biopsy in a Preclinical Setting.在临床前环境中,针对基于 RNA 的液体活检,对人源化弥漫性大 B 细胞淋巴瘤患者来源的肿瘤异种移植模型中的无细胞转录组进行特征分析。
Int J Mol Sci. 2024 Sep 16;25(18):9982. doi: 10.3390/ijms25189982.
3
Extracellular Vesicles as Drug Delivery System for Cancer Therapy.
细胞外囊泡作为癌症治疗的药物递送系统
Pharmaceutics. 2024 Aug 1;16(8):1029. doi: 10.3390/pharmaceutics16081029.
4
A Comprehensive Review on Circulating cfRNA in Plasma: Implications for Disease Diagnosis and Beyond.血浆中循环游离RNA的综合综述:对疾病诊断及其他方面的意义
Diagnostics (Basel). 2024 May 17;14(10):1045. doi: 10.3390/diagnostics14101045.
5
Decoding bioactive signals of the RNA secretome: the cell-free messenger RNA catalogue.解码 RNA 分泌组的生物活性信号:无细胞信使 RNA 目录。
Expert Rev Mol Med. 2024 Apr 29;26:e12. doi: 10.1017/erm.2024.12.
6
Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies.探索弥漫性大B细胞淋巴瘤和原发性纵隔B细胞淋巴瘤患者血浆液体活检中作为生物标志物来源的无细胞总RNA转录组。
Front Oncol. 2023 Oct 25;13:1221471. doi: 10.3389/fonc.2023.1221471. eCollection 2023.
7
Integrated analysis of circulating cell free nucleic acids for cancer genotyping and immune phenotyping of tumor microenvironment.循环游离核酸用于癌症基因分型和肿瘤微环境免疫表型分析的综合研究
Front Genet. 2023 Apr 6;14:1138625. doi: 10.3389/fgene.2023.1138625. eCollection 2023.